V. Diane Woods, Dr.P.H ., M.S.N., R.N. Assistant Research Psychologist
Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health
description
Transcript of Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health
![Page 1: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/1.jpg)
SPECIMEN HANDLING:SPECIMEN HANDLING:from patient bedside from patient bedside to the laboratories to the laboratories
(clinical, commercial (clinical, commercial and public health)and public health)
Patricia A. Somsel, Dr.P.H.Michigan Department of
Community Health
![Page 2: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/2.jpg)
Challenges of Emerging DiseasesChallenges of Emerging Diseases*********KNOWLEDGE GAPS*********
• Epidemiology and Surveillance:– What is the etiologic agent?– How is it transmitted? How infectious is it?– What are the risk factors for acquisition?– What is the case definition? (a moving target)– How long is the agent shed?– When are antibodies demonstrable?– How do we distinguish from other diseases?
![Page 3: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/3.jpg)
*********KNOWLEDGE GAPS******************KNOWLEDGE GAPS*********
• Diagnostic:– How long is the agent shed?– When are antibodies demonstrable?– How do we distinguish clinically from other
diseases?– How stable is the organism?– How can we test for the agent? (sensitivity)– What are the appropriate specimens? (What body
tissues/products carry the organism?)– What cross-rxns can we expect? (specificity)
![Page 4: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/4.jpg)
*********KNOWLEDGE GAPS******************KNOWLEDGE GAPS*********
• Prevention/Safety/(Treatment)– What are the risk factors for acquisition?– How to handle infected patients in health
care setting? In the community? Contacts?– How to protect HCWs?
![Page 5: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/5.jpg)
Health Care Issues Health Care Issues with with
Emerging DiseasesEmerging Diseases
![Page 6: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/6.jpg)
INFECTION CONTROLINFECTION CONTROL• How is the agent transmitted?• How is the agent inactivated?• What, if any, isolation precautions are
necessary for the patient?• What, if any, personal protective
equipment is necessary for HCWs?
![Page 7: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/7.jpg)
![Page 8: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/8.jpg)
INFORMED CONSENTINFORMED CONSENT• For Investigational tests, not yet FDA
approved, performance characteristics not yet verified by testing laboratory
• Confusing to physicians• Confusing to patients• Confusing to labs – what to do w/o
consent?
![Page 9: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/9.jpg)
SPECIMEN COLLECTIONSPECIMEN COLLECTION • What are appropriate specimens for diagnosis
of an emerging disease? Multiple, non-standard, confusing to nursing staff and physicians alike.
-Culture
-Serology
-PCR
-EM/Microscopy• HCWs may lack appropriate training to collect
and hold samples until transported to lab.
![Page 10: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/10.jpg)
Laboratory* Issues Laboratory* Issues with with
Emerging DiseasesEmerging Diseases
* Clinical, Public Health and Commercial
![Page 11: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/11.jpg)
• What specimens may contain viable organism?• What personal protective equipment is
appropriate?• What engineering practices are needed?• Will handling of the agent result in
amplification and an increase in risk for laboratorians?
• How best to store specimens to reduce lability?
LABORATORY SAFETYLABORATORY SAFETYand Specimen Integrityand Specimen Integrity
![Page 12: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/12.jpg)
![Page 13: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/13.jpg)
Packing and ShippingPacking and Shipping• DOT Hazardous Materials Regs
IATA Dangerous Goods Regs• Diagnostic Specimen vs Infectious Substance?• At what temperature? How far do specimens
need to travel?– Room temperature– Refrigerator temperature (2-8oC)– Frozen
• -20oC (freezer packs)• -70oC (dry ice)
![Page 14: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/14.jpg)
![Page 15: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/15.jpg)
Consequences of Shipping Consequences of Shipping Regs for Clinical LabsRegs for Clinical Labs??
• $$$$$$$ Expense to clinical lab which is not reimbursed by third party payers
• Confusion• Lack of compliance• Loss of Specimens unacceptable for testing• Lack of test data to support diagnosis
![Page 16: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/16.jpg)
Public Health Laboratory Public Health Laboratory Issues with Issues with
Emerging DiseasesEmerging Diseases
![Page 17: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/17.jpg)
Public Health Lab Public Health Lab TestingTesting
•Surveillance•Diagnosis
![Page 18: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/18.jpg)
Tests for New DiseasesTests for New Diseases• Historical Perspective
– Syphilis– Lyme Disease– HIV
• Current status of WNV testing• Where will we go with SARS? Monkeypox?
![Page 19: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/19.jpg)
When PH Labs Don’t Do the When PH Labs Don’t Do the Testing……Testing……
• Will PH get a report of positive test?• What test was used?
Does it meet ‘case definition’?• Will a sample be forwarded to a PHL for
‘gold standard’ test if result does not meet ‘case definition’?
![Page 20: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/20.jpg)
![Page 21: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/21.jpg)
ConclusionsConclusions• SPHLs are an essential link between clinical
labs and commercial labs and the federal agencies recognizing new diseases; the health of our citizens and our nation will improve with our cooperation.
• PHLs and manufacturers should collaborate to develop commercial diagnostics for emerging pathogens.
• We’re all in this together.
![Page 22: Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health](https://reader034.fdocuments.in/reader034/viewer/2022051402/56815cbc550346895dcabc42/html5/thumbnails/22.jpg)